LYMELAB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
Key data
Status
KRS number
REGON
NIP/VAT code
VAT registration date
VAT status
Bankruptcy proceedings
LYMELAB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
Contacts
Registered address
Website
-
E
LowestReliability
E - LowestIncorporation date
25/11/2020Share capital
No dataPrimary activity
Research and experimental development on natural sciences and engineeringRepresentatives
0Representatives rights
PRAWO REPREZENTOWANIA SPÓŁKI NA ZEWNĄTRZ PRZYSŁUGUJE KOMPLEMENTARIUSZOWI - LYMELAB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
-5,408,926Net Profit (zł)
-5,408,926Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) |
| Liquidity ratio |
| Net profitability (%) |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 23,700 |
| -1,758,506 |
| -1,758,506 |
| -20.51 |
| 0.63 |
| -7,419.86 |
| -2,349,092 |
| 1,311,046 |
| 2,900,000 |
| - |
| 2023 |
|---|
| 198,646 |
| -2,412,592 |
| -2,412,592 |
| -1.90 |
| 0.76 |
| -1,214.52 |
| -4,661,684 |
| 1,552,089 |
| 5,380,952 |
| - |
| 2024 |
|---|
| 1,651,235 |
| -5,408,926 |
| -5,408,926 |
| -3.68 |
| 0.15 |
| -327.57 |
| -10,070,609 |
| 7,130,679 |
| 8,911,698 |
| - |
| 2024 |
|---|
| 1,651,235 |
| -5,408,926 |
| -5,408,926 |
| -3.68 |
| 0.15 |
| -327.57 |
| -10,070,609 |
| 7,130,679 |
| 8,911,698 |
| - |
2024
Turnover (zł)
1,651,235 zł
731 % *
Profit before tax (zł)
-5,408,926 zł
-124 % *
Net Profit (zł)
-5,408,926 zł-124 % *
Working capital requirement (%)
-3.68 
-93.68 % *
Liquidity ratio
0.15 -80.26 % *
Net profitability (%)
-327.57 %73.03 % *
Equity (zł)
-10,070,609 zł-116 % *
Current liabilities (zł)
7,130,679 zł359 % *
Non current liabilities (zł)
8,911,698 zł66 % *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
LYMELAB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA Documents
Date | Description |
|---|---|
14/09/2025 | OD 01.01.2023 DO 31.12.2023 |
14/09/2025 | OD 01.01.2024 DO 31.12.2024 |
14/09/2025 | OD 22.10.2020 DO 31.12.2021 |
06/08/2025 | OD 01.01.2022 DO 31.12.2022 |